AquaBounty unveils 50,000 tonne target

AquaBounty has announced plans to produce 50,000 tonnes of transgenic salmon annually by 2027 as it bids to raise $9.2 million from investors.

Outlining the company’s goals in a bid to attract investment the company revealed a “near-term business plan… to construct and operate four to five new, land-based RAS farms in North America at locations close to consumer consumption” at the cost of $75 million to $100 million per farm.

Dr Laura Braden with AquAdvantage salmon at AquaBounty's Rollo Bay facility
Dr Laura Braden with AquAdvantage salmon at AquaBounty’s Rollo Bay facility© AquaBounty

The company has a long way to go – its current locations in Rollo Bay, Prince Edward Island and Indiana have the capacity to produce 250 tonnes and 1,200 tonnes respectively. The first harvests from these facilities are expected in the fourth quarter of 2020, and the second quarter of 2020 respectively.  Read the article.


AquaBounty paints bright future as it seeks more cash

Transgenic-salmon grower AquaBounty has outlined ambitious expansion plans as it seeks to raise a further $9.2 million from investors.

These include construction of four to five new farms in North America, each costing between $75m to $100m, at sites close to consumer consumption over the next several years.

Additionally, the company is pursuing regulatory approval for AquAdvantage Salmon in Argentina, Brazil, China, and Israel. If and when approved in these locations, AquaBounty plans to commercialise through a combination of partnerships, joint ventures, and licensing arrangements.

$2.66 per share

The Massachusetts company raised $7.5m in a share sale in March last year following the US Food and Drug Administration’s decision to allow the company to grow and sell its genetically-engineered AquAdvantage salmon in the United States, and followed that in April with a second offer which raised another $5.75m. Shares were offered at $2.25 on each occasion.

AquaBounty, whose fish grow more quickly and use less feed than conventional farmed Atlantic salmon, is now offering more shares at an assumed price of $2.66 per share, which was the closing sale price of its common stock on the Nasdaq Capital Market on January 14.

In its prospectus for the share offer, AquaBounty said it intends to use $2m of funds raised to continue construction and renovation of its 1,200-tonne on-land farm at Albany in Indiana and 250-tonne farm at Rollo Bay on Prince Edward Island, Canada.  Read the article.


AquaBounty, Atlantic Sapphire reveal how they plan to meet surging US salmon demand

At the Future of Food Forum in Gainesville, Florida, on 15 January, seafood industry insiders contended that there will not be enough wild fish to feed the global population in the future. As a result, innovative aquaculture producers are needed to develop sustainable, environmentally-friendly methods to produce greater quantities of fish.

At the event, hosted by the University of Florida’s Institute for Sustainable Food Systems, Christina Espejo, Miami, Florida, U.S.A.-based Atlantic Sapphire’s head of human resources and environmental social action plan (ESAP), said her company was expanding to meet rising consumer interest in salmon.

“There is a growth in demand in consumption of salmon … It is aquaculture that is innovating and coming up with new ways to supply that demand,” Espejo said.

Espejo and AquaBounty President and CEO Sylvia Wulf revealed how the aquaculture firms are producing farmed salmon in a habitat similar to its natural environment – without utilizing antibiotics.

“We can’t harvest enough wild caught fish to be able to meet that seafood consumption. Ocean aquaculture has its challenges [including], we are not gaining more licenses. We need wild caught and ocean pen and creating a different way of farming fish, on land in tanks – what AquaBounty and Atlantic Sapphire are doing,” she said. “I believe that biotechnology is one of the tools we have to embrace to solve global challenges.”

Wulf named world hunger and climate change as two of the most pressing issues that biotechnology can help solve.  Read the article.


GM salmon leaps another legal hurdle. Next up: Another legal hurdle

A federal judge just ruled that, yes, the FDA can regulate a fish as a medicine. His written opinion is kind of a roller coaster for the mind.

Remember the GMO salmon? It was created by a company called AquaBounty back in 1989 and approved by the Food and Drug Administration in November 2015. It’s sold in Canada under the brand name AquAdvantage, and the first batch intended for the U.S. market is quietly growing in an indoor facility in Albany, Indiana. They’re expected to come to market in the U.S. sometime this year.

Or not. The fish, like most other genetically engineered plants and animals, faces adamant opposition in some quarters. Lisa Murkowski, the Republican senator from salmon country–Alaska–has slipped various riders into budget and other bills trying to throw obstacles in AquaBounty’s path. And there’s a longstanding lawsuit brought by a coalition of salmon industry folks and environmentalists that’s trying to completely overturn the approval.

That suit hit an important turning point just before Christmas, when Judge Vince Chhabria of U.S. District Court for the Northern District of California responded to requests for summary judgment in the case, threw out a bunch of claims by the plaintiffs, but let others stand, pending a separate court decision. It’s worth paying attention to, not just for the sake of knowing whether the AquAdvantage is going to find its way into your grocery store, but also because it shows how tricky it can be to get the legal system to do what you want it to.

You can read the opinion for yourself. (Chhabria is the rare judge who produces opinions you can actually read with pleasure.) But to simplify a bit, here’s how the judge responds to the plaintiffs’ main points:  Read the article.


U.S. consumers might get their first taste of transgenic salmon this year

AquaBounty’s fish is the world’s first bioengineered animal approved for human consumption

Inside a row of nondescript buildings in the small town of Albany, in northeast Indiana—approximately 1,000 kilometers from the nearest coast—Atlantic salmon are sloshing around in fiberglass tanks.

Only in the past five years has it become possible to raise thousands of healthy fish so far from the shoreline without contaminating millions of gallons of fresh water. A technology called recirculating aquaculture systems (RAS) now allows indoor aquaculture farms to recycle up to 99 percent of the water they use. And the newest generation of these systems will help one biotech company bring its unusual fish to U.S. customers for the first time this year.

For AquaBounty Technologies, which owns and operates the Indiana facility, this technology couldn’t have come at a better time. The company has for decades tried to introduce a transgenic salmon it sells under the brand name AquAdvantage to the U.S. market. In this quest, AquaBounty has lost between US $100 million and $115 million (so far).

In the final months of 2020, the company will harvest its first salmon raised in the United States and intended for sale there. Thanks to modifications that involved splicing genetic material into its salmon from two other species of fish, these salmon grow twice as fast and need 25 percent less food to reach the same weight as salmon raised on other fish farms.

Since AquAdvantage salmon are genetically modified, the company has taken special precautions to reduce the odds that these fish could reproduce in the wild. Raising all the salmon indoors, far away from wild populations, is key to that equation. And that strategy wouldn’t be possible without modern recirculating systems.  Read the article.


Genetically engineered salmon: An update on how they are growing in Albany

The first batch of genetically engineered salmon eggs that arrived here in May/June has made it from the hatchery into nursery tanks the size of backyard swimming pools and then into grow-out tanks that hold up to 70,000 gallons of water apiece.

The formerly threadlike salmon, the size of the end of your thumbnail, had grown to a length of about 8½ inches and a weight of around 60 grams (about two ounces) by early December and is increasing in size daily, according to AquaBounty Farms-Indiana owner AquaBounty Technologies.

“The first cohort of AquAdvantage Salmon that hatched in our Albany farm in June are healthy and growing well,” AquaBounty spokesman Dave Conley told The Star Press via email.

The fish, engineered to grow faster than conventional Atlantic salmon, are attracting attention because they’re the first genetically modified animals approved for human consumption in the U.S.

The fish were mentioned Dec. 20 by U.S. Sen. Todd Young, R-Ind., when he recapped the farm and agribusiness stops he made in the Hoosier state, including Albany, during 2019.

Young learned about regulatory challenges facing the fish from fellow Sen. Lisa Murkowski, R-Alaska, who reportedly has used riders to single-handedly block genetically engineered (GE) salmon for years. Murkowski’s office told The Star Press her efforts are all about ensuring clear labeling of GE salmon before they go to market.

The batch of conventional Atlantic salmon that AquaBounty started farming in June of 2018 is growing well and is expected to be harvested beginning in the third quarter of  2020, followed by the first harvest of the GE AquAdvantage Salmon in the fourth quarter of 2020, according to Conley.

A second batch of AquAdvantage Salmon eggs arrived at the land-based farm in Albany in mid-October, has now hatched and is almost ready to be moved to the nursery for their first feeding.


AquaBounty criticizes Murkowski GE salmon rider

Genetically modified salmon supplier AquaBounty is criticizing “vague” new requirements for GM-salmon labeling that were included in the Fiscal Year 2020 appropriations bill, which is expected to pass in the U.S. Senate this week.

The National Bioengineered Food Disclosure Standard, which passed in May 2018, requires genetically modified foods to be labeled “bioengineered.” But U.S. Senator Lisa Murkowski (R-Alaska) attached a rider to this year’s appropriations bill, which would require GM salmon approved prior to the standards being passed to include “genetically engineered” on its labeling

”Notwithstanding any other provision of law, the acceptable market name of any engineered animal approved prior to the effective date of the National Bioengineered Food Disclosure Standard shall include the words ‘genetically engineered’ prior to the existing acceptable market name,” Murkowski’s rider states.

While the new language “will finally allow us to commercialize our FDA-approved bioengineered salmon, we believe it is completely unnecessary,” AquaBounty said in a press release. “Senator Murkowski continues to single out a small, innovative, American company in a misguided attempt to protect a parochial special interest when, in reality, the rider most benefits Chilean and Norwegian companies that currently export more Atlantic salmon to the U.S. than any American company produces.”

Because AquaBounty’s salmon is “safe and identical to other farm-raised Atlantic salmon, this provision sets a dangerous precedent for all bioengineered foods because it was passed as an appropriations rider, yet has nothing to do with funding, and it imposes a mandate that targets a single company and product and calls into question the regulatory process and federal disclosure requirements,” AquaBounty added.  Read the article.


RAS believers making an early stand on American soil

Domestically produced, fresh Atlantic salmon is hitting the U.S. marketplace. That’s nothing new.

What is new is that these fish aren’t from traditional ocean-based farms. They’re from land-based aquaculture facilities in places most people wouldn’t expect.

For industry insiders, the emergence of land-based aquaculture is not too surprising, seen as a response to demand for Atlantic salmon and locally produced food with a low environmental footprint. Despite the considerable expense to build a suitable facility that can produce fish at commercial scale, two prominent producers are making waves with this market-leading species, recirculating aquaculture systems (RAS) and are poised to make an early stand in the United States.

The first RAS producer to bring Atlantic salmon to market did so this past July, when Superior Fresh LLC harvested its first batch at its facility in Northfield, Wisc., a thousand miles from the nearest ocean.

Superior Fresh operates an aquaponics RAS system that produces Atlantic salmon and steelhead trout in conjunction with leafy greens. Its certified-organic produce, fertilized by the fish waste, has been on the market since 2018, but the first yield of market-sized salmon staked the company’s claim as RAS pioneers. In celebration, Superior Fresh announced an expansion plan at its current facility to increase production almost tenfold. Construction is in the works for a new facility that will increase their yield from its current 160,000 pounds (80 metric tons) to 1.5 million pounds (750 MT) annually by 2022.

Atlantic Sapphire is also carving out its position as a leader in U.S. Atlantic salmon production, even though its fish are not yet on the market. The Denmark-based company has a facility under construction outside of Miami, Fla., with some fish already in smolt stage of production. The company expects to harvest its first market-sized yield next summer, with an eye on annual production of about 90,000 MT by 2026.  Read the article.

Editor’s note:  All of the benefits stated for the firms mentioned in the article apply to AquaBounty’s salmon, except ours grows to market size faster.


Opinion: Murkowski is stifling innovation

Sen. Lisa Murkowski’s recent column in these pages touted her many efforts to support Alaskan fisheries and fishermen. I couldn’t agree more with her goals and support the solutions she puts forward that will enhance the livelihood of this great state while enabling more American families to have fresh, healthy salmon on their plates.

Where I disagree with the senator is when the policies she seeks move from support for Alaska to attacking new and innovative efforts by others to bring fresh, healthy salmon to market. And while Murkowski is specifically working to undermine a single company she views as a threat to the Alaska fish industry, her efforts could have a chilling effect on innovators from all industries, both in Alaska and around the country, who now need to fear that their years of investment and research and seeking regulatory approval can all be undone by the efforts of a single senator.

As Alaskans well know, there is no substitute for the high-quality Alaskan salmon caught by tens of thousands of fishermen in this great state. While Alaskan fisheries are to be applauded for their decades of excellent product, the Pacific salmon industry alone cannot feed our country, nor is it sustainable to think it can simply increase production from already over-fished seas.

Like Alaskan salmon, Atlantic salmon are essential to feeding and nourishing a healthy America. Atlantic salmon have been both caught and farmed for decades, providing a different and less expensive alternative to Alaskan and other Pacific salmon for millions of consumers. Unfortunately, the United States currently lacks a sustainable means of providing enough salmon to meet the ever-growing demand of millions of American families across the country. This shortfall is so great, that the United States currently imports 90% of the Atlantic salmon consumed in America from countries like Norway and Chile.

A small, Massachusetts-based company, AquaBounty Technologies, has made its mission to find a sustainable solution to this problem. After 20 years of research and development and countless approvals, AquaBounty is on the cusp of bringing its domestically-raised seafood to communities across the country. Through robust innovation and rigorous testing, AquaBounty has developed a way to use genetic engineering to farm-raise salmon in closed environments that can help meet demand. What’s more, these closed environments are isolated from wild fish populations and pose no risk to any other salmon.  Read the article.


Warming up to climate change

The inconvenient truth about climate change is that not only are temperature changes affecting our natural ecosystems, it’s also causing us to rethink the way we do things, both as consumers and as an industry.

Whether it’s in our personal consumption or in the industrial realm, climate change is forcing us to face the reality that we simply cannot go on the way we used to and expect the climate crisis to resolve on its own. Sustainable production, supply and consumption of goods and services need to be more deliberate to have a more meaningful impact.

The recent deaths of some 2.6 million farmed salmon in Newfoundland in Canada brings the devastating effects of climate change closer to home.

Northern Harvest Sea Farms, a subsidiary of Mowi Canada, suffered a significant setback last fall after roughly 5,000 tons of fish died in the net pens, resulting in the temporary suspension of the company’s farming licences. Company representatives blamed the massive mortalities to an extended period of higher-than-usual sea water temperatures that lasted up to 13 days.  Read the article.


Study to look into role of RAS in addressing US seafood deficit

Could Atlantic salmon farmed in recirculating aquaculture systems (RAS) help narrow down the United States’ growing seafood trade deficit? This is one of the many questions that an initiative launched in September aims to address.

Called the National Coordinated Recirculating Aquaculture System Network, the initiative has received $1.2 million in funding from NOAA’s National Sea Grant Office.

It aims to develop a “roadmap” for policymakers and federal agencies in promoting an economically feasible and environmentally sustainable land-based domestic aquaculture industry.

Maryland Sea Grant and University of Maryland, Baltimore County, are lead partners in the initiative. Industry collaborators, which matched the fund from NOAA, include Superior Fresh in Wisconsin, Whole Oceans and Nordic Aquafarms in Maine, and American Salmon in Maryland.  Read the article.


Jim Anderson: Fillets might replace drumsticks at Thanksgiving in future

While you enjoy a turkey feast for Thanksgiving, public scientists are thinking about what’ll be on your holiday table 20 years from now. There’s a good chance it’ll be something other than turkey.

I predict that much of it is going to come from farming the sea. Aquaculture — fish farming — now accounts for more than half of the world’s seafood. In the United States, four of the top five seafoods consumed — shrimp, salmon, tilapia and catfish — are dominated by fish farming.

U.S. shrimp consumption per person has more than doubled in the past three decades, salmon consumption has gone up five times and tilapia was not even in the market three decades ago. But we haven’t seen anything yet.

Aquaculture is an efficient way to raise food. Anyone who’s sprinkled fish food in an aquarium can understand that you don’t need truckloads of food to grow fish. They need water to swim, but not to drink, so they’re not a drain on water resources.  Read the article.


UF Announces Future of Food Forum

Future of Food Forum will be held on the University of Florida (UF) campus, Gainesville Florida, on January 15, 2020.

The Institute for Sustainable Food Systems within the UF Institute for Food and Agricultural Sciences is hosting this Forum to bring together leaders, innovators and experts spanning the global food system to explore what the future of food will look like in 2050, how we will get there and the role of the private sector, universities and governing institutions.

The keynote speaker, Dr. Louise Fresco, President of Wageningen University in the Netherlands, will focus on responsible agriculture and food consumption as crucial to world stability.

At the forum you will hear some of the world’s changemakers give their perspective on the future of food systems and what we should be doing now to embrace the innovations and challenges of the future of food. There will be four high impact sessions:

The Innovators – Hear from inventors and entrepreneurs who are shaping the future of food.

Food from the Land – Panelists will discuss new technologies: what will be useful, who will use them, where will they be most useful, and what the impacts will be.

Food from the Sea – Analysts will present the state of current seafood systems; predictions for future trends in aquaculture and fisheries.

Food and Human Well-Being – One Health perspectives on health and food including antimicrobial resistance, foodborne disease, and nutrition.

This will be an insightful event for anyone who cares about the future of food – from producers to consumers; from researchers to innovators; and from business leaders to policymakers.

More details and registration information are available on the Future of Food Forum website.

Please note: Aquaculture and fisheries presentations are a prominent part of the agenda including The Innovators:

Johan AndreassenCEO, Atlantic Sapphire, Miami, FL
Matthew JohnstonHead, Global Vegetable Seeds and Flowers, Syngenta, Downers Grove, IL
Sylvia WulfPresident/CEO, AquaBounty, Maynard, MA
Dickson DespommierProf Emeritus, Environmental Health Sci, Columbia University & Author of The Vertical Farm: Feeding the World in the 21st
Gary WishnatzkiCo-Founder, Harvest CROO Robotics/Owner, Wish Farms, Plant City, FL
Andy JarvisDirector of the Decision and Policy Analysis, International Centre for Tropical Agriculture, (CIAT), Cali, Colombia

Ocean warming assessment illustrates climate challenge facing salmon farming

The temperature challenge facing Scotland’s salmon farmers has been illustrated by a new report on how ocean warming, especially of the North Atlantic, is affecting the mix of species in the seas.

Although the assessment is focused on wild species and not farmed fish, the trend it shows indicates a potential long-term problem for Scottish salmon farmers who have pointed to unusually high average sea temperatures as one of the reasons for an increase in mortalities this year.

A map with the assessment shows increases in the populations of warm-water species around coasts of northern Europe, including the west coast of Scotland.

Species mix

Warmer water is linked with an increase in harmful algal blooms which can kill fish by lowering the amount of dissolved oxygen in the water, and cause disease by damaging the fish’s gills.

An international group of marine scientists led by Professor Michael Burrows of the Scottish Association for Marine Science (SAMS) in Oban has compiled the comprehensive assessment of how ocean warming is affecting the species mix. It is published in the journal Nature Climate Change.

Researchers analysed three million records of thousands of species from 200 ecological communities from the North Atlantic, Western Europe, Newfoundland and the Labrador Sea, east coast USA, the Gulf of Mexico, and the North Pacific from California to Alaska.  Read the article.


Genetically modified salmon to be sold in the U.S.

On the outskirts of Albany, a town in the U.S. state of Indiana, a pair of nondescript, factory-sized white buildings are located. It is here that biotechnology firm AquaBounty Technologies is producing genetically modified (GM) salmon, scheduled to hit the U.S. market next year. The company hopes that the fish will become the first genetically engineered animal to be produced and consumed in the U.S.

The genetically modified salmon grow quickly – reaching market size in half the time as conventional salmon. Gene manipulation allows the salmon to grow year round, instead of just in spring and summer. The process was first developed by Canadian researchers thirty years ago. Silvia Wulf, chief executive and president of AquaBounty Technologies explained that the process involved taking a gene from a Chinook salmon and injected it into an Atlantic salmon.

But, one area of concern is containment. Some worry about what would happen if the fish were to escape into nearby rivers and streams, potentially becoming an invasive species.

According to farm manager Peter Bowyer, a range of measures are in place. “We take it really seriously. We are in Indiana where there aren’t any salmon,” he said. “The fish are sterile. They are all female. But even after all of that, we still have physical barriers in place,” Bowyer explained.  Read the article.

Genetically modified salmon to hit US markets

Genetically modified food is a hot topic.

Already, the majority of corn and soy grown in the U.S. has been genetically modified.

But the science has also reached a range of other consumer products, and that includes salmon, which is set to hit U.S. restaurants and markets next year.

Genetically modified salmon grow quickly, reaching market size in half the time as conventional salmon.

Gene manipulation allows the salmon to grow year round — not just in spring and summer.

The process was first developed by Canadian researchers 30 years ago.

“He took a gene from a chinook salmon and he injected that into an Atlantic salmon,” said Sylvia Wulf, chief executive and president of AquaBounty Technologies. “Because it is one gene from a chinook and 44,000 genes from an Atlantic salmon, that actually accelerates its growth at its most vulnerable stages.”

One area of concern is containment and what would happen if the fish were to escape into nearby streams and rivers, potentially becoming an invasive species.

Farm manager PeterBowyer says the company has a range of measures in place.  Read the article.


Gone global?

The assault on genetically modified salmon coming from Sen. Lisa Murkowski, R-Alaska, and others appear to be making life difficult for the company trying to bring the fast-growing fish to market.

Whether that is a good thing or a bad thing only time will tell given that AquaBounty CEO Sylvia Wulf has now told SeafoodSource the company is looking to farm its salmon overseas.

“China is of significant interest to us, and we’re having a couple conversations with partners over there to build the next farm,” Wulf told SeafoodSource reporter Chris Chase. “We have approval for field trials in China, and the Chinese government has been very receptive in trying to navigate the regulatory approval process.”

She said the company is also exploring the possibility of building a recirculating aquaculture system (RAS) farms in Brazil and Israel, a country at the forefront of agriculture technology. 

North American efforts to eliminate or limit the sale of the fish – at the Canadian Seafood Show in Montreal in September the Aquaculture Stewardship Council said it will not certify genetically modified (GM) salmon – is no guarantee the spread of the fast-growing fish will be slowed given its apparent market advantages.

AquaBounty claims its salmon are 25 percent more efficient than non-GM salmon in converting feed to body mass and reach marketable size 8- to 10-months faster than non-GM salmon.  Read the article.


AquaBounty aiming to build new RAS sites overseas

For more than two decades, AquaBounty has been developing its genetically modified AquAdvantage salmon, which the company plans to grow in land-based recirculating aquaculture systems (RAS).

Since the company gained regulatory approval, and finally had an import alert lifted by the U.S. Food and Drug Administration in May, the it has been busy growing the first batches of genetically modified salmon at its land-based facility in Indiana. That step was a big moment for the company, AquaBounty CEO Sylvia Wulf told SeafoodSource.

“I think the next-biggest moment for us was when we imported our first batch of AquAdvantage salmon eggs, and they went into the Indiana farm in late May,” Wulf said. “And we just imported our second batch. The fact that we have fish in the water, and another batch of eggs that are going to hatch, that’s a huge thing for us.”

Thus far, all signs point to the process being successful, Wulf said. Now that its salmon has started its growing process, the company is already setting its sights on developing markets for the product, both in the United States and abroad.

The company’s core concept of producing salmon in land-based aquaculture has allowed it to set its site on producing salmons in locations – and countries – that have a robust demand for salmon, Wulf said.

“We’ve begun conversations with a number of states in the U.S. in terms of where the next facility will be,” Wulf said. “We’re looking at probably three to five different sites in the U.S., we’re looking at additional sites in Canada as well.”

The main requirement for the production facility, Wulf said, is that it needs to have an adequate supply of groundwater. AquaBounty has been raising salmon in freshwater for years, without any need for a saltwater phase, allowing the company to be flexible when it comes to selecting a site for a facility.

Wulf said the company also aspires to take its aquaculture model overseas.  Read the article.


GM salmon set for Q4 2020 harvest

AquaBounty has announced that it expects to harvest the first of its genetically modified AquAdvantage salmon from its farm in Indiana by the end of 2020.

Its Q3 report, published this week, reports that the firm currently has 77 tonnes of salmon at its RAS farm in Indiana.

However, they explained to The Fish Site, this tonnage is accounted for by a cohort of conventional Atlantic salmon. The next cohort, which was stocked in June 2019, consists of its GM AquAdvantage strain, the first of which are destined to be harvested in Q4 2020.

Meanwhile in the company’s Q3 report, Sylvia Wulf, CEO, stated: “We are thrilled with the progress of our salmon at our Indiana farm. The fish are growing extremely well, and they look fantastic. A new batch of AquAdvantage salmon eggs was recently received at the farm, and we now have three cohorts of fish in the water. Every day we move closer to our first harvests, which we expect to commence in June of next year.”

On a less positive note the North American company reported losses of $9.8 million for the nine-month period up to the end of September, up from $8 million in the corresponding period of 2018.

The company attributes these losses to “increases in production operations, headcount, and legal fees in support of the US Food and Drug Administration’s (FDA) defence of their approval of AquAdvantage salmon.”  Read the article.


Leading by example: how AquaBounty, Oxford Biomedica, and Berkeley Lights have successfully brought products to market

Chances are, you’ve personally used or benefitted from bioproducts – products made from renewable biologic materials. Alternative protein sources such as the Impossible Burger and Pivot Bio’s nitrogen-fixing PROVEN™ fertilizer are just two of many successful bioproducts. In December, North Face Japan will offer the Moon Parka – a high-performance ski parka manufactured with Spiber, Inc.’s  bioengineered spider silk. Geltor’s HumaColl21TM , a biocompatible collagen for human skin cells, is a key component of Kolam Korea’s anti-aging face cream.  Once bioproducts like these reach the market, it’s easy to overlook the fact that the work needed to adapt a biological process for use in the manufacture of a marketable product is just one step in a complex series of steps necessary for success.  Read the article.

“What I really admire about [AquaBounty],” says Hallinan, “is that they had the persistence to just keep going” even when the public wasn’t ready for their product and they had to continue on despite that. “I think that on a larger scale, aquaculture is going to become increasingly important as we start to reduce the use of protein sources with significant greenhouse gas impacts like beef and pork.”